1. Home
  2. OSPN vs HELP Comparison

OSPN vs HELP Comparison

Compare OSPN & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

N/A

Current Price

$22.22

Market Cap

946.7M

Sector

Technology

ML Signal

N/A

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$8.94

Market Cap

862.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSPN
HELP
Founded
1991
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
946.7M
862.2M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
OSPN
HELP
Price
$22.22
$8.94
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$23.50
★ $41.56
AVG Volume (30 Days)
888.5K
★ 1.4M
Earning Date
10-29-2026
11-24-2026
Dividend Yield
★ 2.32%
N/A
EPS Growth
★ 28.77
N/A
EPS
★ 0.68
N/A
Revenue
★ $243,180,000.00
N/A
Revenue This Year
$5.28
N/A
Revenue Next Year
$2.44
N/A
P/E Ratio
$33.17
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.07
$3.76
52 Week High
$27.45
$15.15

Technical Indicators

Market Signals
Indicator
OSPN
HELP
Relative Strength Index (RSI) 56.84 40.70
Support Level $21.29 $4.41
Resistance Level $27.45 $11.74
Average True Range (ATR) 1.24 0.80
MACD -0.14 -0.00
Stochastic Oscillator 37.47 26.77

Price Performance

Historical Comparison
OSPN
HELP

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: